Page 7 - ESHRE2019

SCIENTIFIC PROGRAMME
09:00 - 09:30
09:30 - 09:45 09:45 - 10:15
10:15 - 10:30 10:30 - 11:00
11:00 - 11:30
11:30 - 11:45 11:45 - 12:15
12:15 - 12:30 12:30 - 13:30
13:30 - 14:00
14:00 - 14:15 14:15 - 14:45
14:45 - 15:00 15:00 - 15:30
15:30 - 16:00
16:00 - 16:15 16:15 - 16:45
16:45 - 17:00
Chair: Johnny Awwad, Lebanon
Pre-IVF treatment of endometriosis: What, when and for how long?
Johnny Awwad, Lebanon Discussion
Pre-IVF treatment of uterine fibroids: When does intervention become beneficial?
Mohamed Aboulghar, Egypt
Discussion Coffee break
Chair: Michel Abou Abdallah, Lebanon
Pre-IVF treatment of uterine adenomyosis: Is intervention useful at all?
Togas Tulandi, Canada
Discussion
Pre-IVF treatment of severe tubal disease: To treat or not to treat?
John Petrozza, U.S.A. Discussion
Lunch break
Chair: Michel Abou Abdallah, Lebanon
Pre-IVF treatment of uterine cavity defects: The do’s and the don’ts
Togas Tulandi, Canada
Discussion
Pre-IVF thyroid function screening –why test, what to test and how to interpret
Lubna Pal, U.S.A. Discussion Coffee break
Chair: Mohamed Aboulghar, Egypt
Pre-IVF management of PCOS: How significant is the role of insulin sensitizers?
Lubna Pal, U.S.A.
Discussion
Pre-IVF management of poor response: Much ado about nothing?
John Petrozza, U.S.A. Discussion
PRECONGRESS COURSE 16 I VIENNA, AUSTRIA – 23 JUNE 2019 05